Clinical Trials Directory

Trials / Terminated

TerminatedNCT03613493

Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention

Acceptability of HPV Self-sampling Tools for Cervical Cancer Prevention in Jamaican Women: A Theory-based Approach to Culturally-tailored Message Design

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
175 (actual)
Sponsor
University of Miami · Academic / Other
Sex
Female
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

The proposed study aims to increase HPV screening behaviors in Jamaican women by examining the acceptability of HPV Deoxyribonucleic Acid (DNA) self-sampling tools, and to determine the most culturally appropriate and effective message design for promoting such a tool in this context.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHPV self-sampling kitThe HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
BEHAVIORALCulturally-targeted Fear Appeal MessageParticipants will receive culturally-targeted and fear appeal messages in a graphically designed kit.
BEHAVIORALFear Appeal MessageParticipants will receive fear appeal messages (only) in a graphically designed kit.
BEHAVIORALInterviewParticipants will be interviewed about experiences using the self-sampling tool (qualitative).

Timeline

Start date
2018-07-10
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2018-08-03
Last updated
2019-08-02
Results posted
2019-08-02

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03613493. Inclusion in this directory is not an endorsement.